The effect of coronary angioplasty on plasma NT‐proBNP level in patients with and without arterial hypertension

References

• Kelly R., Struthers A. D. Are natriuretic peptides clinically useful as markers of heart failure?. Ann Clin Biochem 2001; 38: 94–102
   Google Scholar
• Adams K. F., Jr., Mathur V. S., Gheorghiade M. B‐type natriuretic peptide from bench to bedside. Am Heart J 2003; 145(Suppl)34–46
   Google Scholar
• McDonagh T. A., Robb S. D., Murdoch D. R., Morton J. J., Ford I., Morrison C. E., et al. Biochemical detection of left‐ventricular systolic dysfunction. Lancet 1998; 351: 9–13
   PubMed Web of Science ®Google Scholar
• Cowie M. R., Struthers A. D., Wood D. A., Coats A. J., Thompson S. G., Poole‐Wilson P. A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1349–1353
   PubMed Web of Science ®Google Scholar
• Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., et al. Utility of B‐natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105: 595–601
   PubMed Web of Science ®Google Scholar
• Wieczorek S. J., Bailly K. R., Thomas P., Wu A. H. B., Hager D., Ferrier A., et al. Clinical evaluation of the Triage B‐type natriuretic peptide assay for the point of care testing of patients with congestive heart failure. Clin Chem 2000; 46: A77
   Google Scholar
• Hunt P. J., Richards A. M., Nicholls M. G., Yandle T. G., Doughty R. N., Espiner E. A. Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐proBNP): A new marker of cardiac impairment. Clin Endocrinol 1997; 47: 287–296
   PubMed Web of Science ®Google Scholar
• Talwar S., Squire I. B., Downie P. F., Davies J. E., Ng L. L. Plasma N terminal pro‐brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 2000; 84: 421–424
   PubMed Web of Science ®Google Scholar
• Bibbins‐Domingo K., Ansari M., Schiller N. B., Massie B., Whooley M. A. B‐type natriuretic peptide and ischemia in patients with stable coronary disease: Data from the Heart and Soul study. Circulation 2003; 108: 2987–2992
   PubMed Web of Science ®Google Scholar
• de Lemos J. A., Morrow D. A., Bentley J. H., Omland T., Sabatine M. S., McCabe C. H., et al. The prognostic value of B‐type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014–1021
   PubMed Web of Science ®Google Scholar
• Horio T., Shimada K., Kohno M., Yoshimura T., Kawarabayashi T., Yasunari K., et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J 1993; 126: 293–299
   Google Scholar
• Jiang C. Y., Li N., Wang J. A. Use of B‐type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndromes. Chin Med J 2004; 117: 1130–1134
   Google Scholar
• Katayama T., Nakashima H., Yonekura T., Honda Y., Suzuki S., Yano K. Clinical significance of acute‐phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty. J Cardiol 2003; 42: 195–200
   PubMedGoogle Scholar
• de Winter R. J., Stroobants A., Koch K. T., Bax M., Schotborgh C. E., Mulder K. J., et al. Plasma N‐terminal pro‐B‐type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. Am J Cardiol 2004; 94: 1481–1485
   PubMed Web of Science ®Google Scholar
• Kyriakides Z. S., Markianos M., Michalis L., Antoniadis A., Nikolaou N. I., Kremastinos D. T. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 2000; 23: 285–288
   PubMedGoogle Scholar
• Tateishi J., Masutani M., Ohyanagi M., Iwasaki T. Transient increase in plasma brain (B‐type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000; 23: 776–780
   PubMedGoogle Scholar
• Goetze J. P., Christoffersen C., Perko M., Arendrup H., Rehfeld J. F., Kastrup J., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105–1107
   PubMed Web of Science ®Google Scholar
• Palazzuoli A., Carrera A., Calabria P., Pastore M., Quatrini I., Vecchiato L., et al. Brain natriuretic peptide levels during cardiac reperfusion: Comparison between percutaneous coronary angioplasty and aorto‐coronaric bypass. Clin Chim Acta 2004; 342: 87–92
   Google Scholar
• Braunwald E. Stunning of the myocardium: An update. Cardiovasc Drugs Ther 1991; 5: 849–851
   PubMedGoogle Scholar
• Alam M., Khaja F., Brymer J., Marzelli M., Goldstein S. Echocardiographic evaluation of left ventricular function during coronary artery angioplasty. Am J Cardiol 1986; 57: 20–25
   PubMedGoogle Scholar
• Doorey A. J., Mehmel H. C., Schwarz F. X., Kubler W. Amelioration by nitroglycerin of left ventricular ischemia induced by percutaneous transluminal coronary angioplasty: Assessment by hemodynamic variables and left ventriculography. J Am Coll Cardiol 1985; 6: 267–274
   Google Scholar
• Serruys P. W., Wijns W., van den Brand M., Meij S., Slager C., Schuurbiers J. C., et al. Left ventricular performance, regional blood flow, wall motion and lactate metabolism during transluminal angioplasty. Circulation 1984; 70: 25–36
   Google Scholar
• Hauser A. M., Gangadharan V., Ramos R. G., Gordon S., Timmis G. C. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: Echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985; 5: 193–197
   PubMed Web of Science ®Google Scholar
• Visser C. A., David G. K., Kan G., Romijn K. H., Meltzer R. S., Koolen J. J., et al. Two‐dimensional echocardiography during percutaneous transluminal coronary angioplasty. Am Heart J 1986; 111: 1035–1041
   Google Scholar
• Wohlgelernter D., Cleman M., Highman H. A., Fetterman R. C., Duncan J. S., Zaret B. L., et al. Regional myocardial dysfunction during coronary angioplasty: Evaluation by two‐dimensional echocardiography and 12 lead electrocardiography. J Am Coll Cardiol 1986; 7: 1245–1254
   Google Scholar
• Wijns W., Serruys P. W., Slager C. J., Grimm J., Krayenbuehl H. P., Hugenholtz P. G., et al. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure‐radius relations. J Am Coll Cardiol 1986; 7: 455–463
   PubMed Web of Science ®Google Scholar
• Carlson E. B., Hinohara T., Morris K. G. Recovery of systolic and diastolic left ventricular function after a 60‐second coronary arterial occlusion during percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1987; 60: 460–466
   Google Scholar
• Kloner R. A., Jennings R. B. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1. Circulation 2001; 104: 2981–2989
   PubMed Web of Science ®Google Scholar
• Verma S., Fedak P. W., Weisel R. D., Butany J., Rao V., Maitland A., et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002; 105: 2332–2336
   PubMed Web of Science ®Google Scholar
• Granger D. N. Ischemia‐reperfusion: Mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation 1999; 6: 167–178
   PubMed Web of Science ®Google Scholar
• Baxter G. F. Natriuretic peptides and myocardial ischaemia. Basic Res Cardiol 2004; 99: 90–93
   PubMed Web of Science ®Google Scholar
• Toth M., Vuorinen K. H., Vuolteenaho O., Hassinen I. E., Uusimaa P. A., Leppaluoto J., et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 1994; 266: H1572–H1580
   PubMedGoogle Scholar
• D'Souza S. P., Yellon D. M., Martin C., Schulz R., Heusch G., Onody A., et al. B‐type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 2003; 284: H1592–H1600
   Google Scholar
• Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995; 92: 1558–1564
   PubMed Web of Science ®Google Scholar
• Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82–91
   PubMed Web of Science ®Google Scholar
• Mukoyama M., Nakao K., Obata K., Jougasaki M., Yoshimura M., Morita E., et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991; 180: 431–436
   PubMed Web of Science ®Google Scholar